Status:
COMPLETED
Safety and Efficacy of a New Ophthalmic Formulation of Bimatoprost in Patients With Open Angle Glaucoma and Ocular Hypertension
Lead Sponsor:
Allergan
Conditions:
Open-Angle Glaucoma
Ocular Hypertension
Eligibility:
All Genders
18+ years
Phase:
PHASE1
PHASE2
Brief Summary
This study will evaluate the safety and efficacy of new ophthalmic formulations of bimatoprost in patients with open angle glaucoma and ocular hypertension. At least 3 dose strengths will be evaluated...
Eligibility Criteria
Inclusion
- Diagnosis of open angle glaucoma or ocular hypertension
Exclusion
- Uncontrolled medical conditions
- Anticipated wearing of contact lenses during the study
Key Trial Info
Start Date :
September 23 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 9 2016
Estimated Enrollment :
109 Patients enrolled
Trial Details
Trial ID
NCT01157364
Start Date
September 23 2010
End Date
August 9 2016
Last Update
March 30 2020
Active Locations (57)
Enter a location and click search to find clinical trials sorted by distance.
1
Sall Research Medical Center
Artesia, California, United States, 90701
2
Shiley Eye Center, Hamilton Glaucoma Center, University of California, San Diego
La Jolla, California, United States, 92093
3
Doheny Eye Institute
Los Angeles, California, United States, 90033
4
Martel Eye Medical Group
Rancho Cordova, California, United States, 95670